Cantor Fitzgerald Weighs in on PRQR FY2026 Earnings
ProQR Therapeutics (NASDAQ:PRQR – Free Report) – Equities researchers at Cantor Fitzgerald issued their FY2026 EPS estimates for shares of ProQR Therapeutics in a report issued on Monday, June 9th. Cantor Fitzgerald analyst S. Seedhouse expects that the biopharmaceutical company will earn ($0.50) per share for the year. Cantor Fitzgerald has a “Overweight” rating and […]
ProQR Therapeutics (NASDAQ:PRQR – Free Report) – Equities researchers at Cantor Fitzgerald issued their FY2026 EPS estimates for shares of ProQR Therapeutics in a report issued on Monday, June 9th. Cantor Fitzgerald analyst S. Seedhouse expects that the biopharmaceutical company will earn ($0.50) per share for the year. Cantor Fitzgerald has a “Overweight” rating and […]
